| Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19) JJA van Kampen, DAMC van de Vijver, PLA Fraaij, BL Haagmans, ... Nature communications 12 (1), 267, 2021 | 690 | 2021 |
| An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment CH GeurtsvanKessel, NMA Okba, Z Igloi, S Bogers, CWE Embregts, ... Nature communications 11 (1), 3436, 2020 | 367 | 2020 |
| Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants JJA van Kampen, DAMC van de Vijver, PLA Fraaij, BL Haagmans, ... MedRxiv, 2020.06. 08.20125310, 2020 | 251 | 2020 |
| Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis M Goeijenbier, JJ Van Kampen, CB Reusken, MP Koopmans, ... Neth J Med 72 (9), 442-8, 2014 | 221 | 2014 |
| Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1–2 safety and feasibility study S Cohen, J Roy, S Lachance, JS Delisle, A Marinier, L Busque, DC Roy, ... The Lancet Haematology 7 (2), e134-e145, 2020 | 188 | 2020 |
| Miscarriage associated with Zika virus infection AA van der Eijk, PJ van Genderen, RM Verdijk, CB Reusken, R Mögling, ... New England Journal of Medicine 375 (10), 1002-1004, 2016 | 176 | 2016 |
| Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection A Gharbharan, CCE Jordans, C GeurtsvanKessel, JG den Hollander, ... Nature communications 12 (1), 3189, 2021 | 168 | 2021 |
| Biomedical application of MALDI mass spectrometry for small‐molecule analysis JJA van Kampen, PC Burgers, R de Groot, RA Gruters, TM Luider Mass spectrometry reviews 30 (1), 101-120, 2011 | 164 | 2011 |
| Current and future applications of dried blood spots in viral disease management IJM Snijdewind, JJA van Kampen, PLA Fraaij, ME van der Ende, ... Antiviral research 93 (3), 309-321, 2012 | 158 | 2012 |
| Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial I Wijting, C Rokx, C Boucher, J van Kampen, S Pas, T de Vries-Sluijs, ... The lancet HIV 4 (12), e547-e554, 2017 | 141 | 2017 |
| Characterization of β-lactamase enzyme activity in bacterial lysates using MALDI-mass spectrometry GP Hooff, JJA van Kampen, RJW Meesters, A van Belkum, ... Journal of proteome research 11 (1), 79-84, 2012 | 103 | 2012 |
| COVID‐19 in solid organ transplant recipients: a single‐center experience RAS Hoek, OC Manintveld, MGH Betjes, ME Hellemons, L Seghers, ... Transplant International 33 (9), 1099-1105, 2020 | 93 | 2020 |
| HIV-1 resistance dynamics in patients with virologic failure to dolutegravir maintenance monotherapy IEA Wijting, C Lungu, BJA Rijnders, ME van der Ende, HT Pham, ... The Journal of infectious diseases 218 (5), 688-697, 2018 | 84 | 2018 |
| Human bocavirus infection as a cause of severe acute respiratory tract infection in children FM Moesker, JJA Van Kampen, AA van der Eijk, AMC van Rossum, ... Clinical Microbiology and Infection 21 (10), 964. e1-964. e8, 2015 | 79 | 2015 |
| Clinical characteristics and outcomes of immunocompromised patients with coronavirus disease 2019 caused by the omicron variant: a prospective, observational study SRK Malahe, RAS Hoek, VASH Dalm, AEC Broers, CM Den Hoed, ... Clinical Infectious Diseases 76 (3), e172-e178, 2023 | 77 | 2023 |
| Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots RJW Meesters, JJA van Kampen, ML Reedijk, RD Scheuer, LJM Dekker, ... Analytical and bioanalytical chemistry 398, 319-328, 2010 | 77 | 2010 |
| Qualitative and quantitative analysis of pharmaceutical compounds by MALDI-TOF mass spectrometry JJA van Kampen, PC Burgers, R de Groot, TM Luider Analytical chemistry 78 (15), 5403-5411, 2006 | 76 | 2006 |
| Cell-line dependent antiviral activity of sofosbuvir against Zika virus N Mumtaz, LC Jimmerson, LR Bushman, JJ Kiser, G Aron, ... Antiviral research 146, 161-163, 2017 | 68 | 2017 |
| Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun. 2021; 12 (1): 267 JJA Van Kampen, D van de Vijver, PLA Fraaij, BL Haagmans, MM Lamers, ... Considering that viral replication and transcription occurs in double …, 0 | 67 | |
| Primary polyomavirus infection, not reactivation, as the cause of trichodysplasia spinulosa in immunocompromised patients E van der Meijden, B Horváth, M Nijland, K de Vries, E Rácz, GF Diercks, ... The Journal of infectious diseases 215 (7), 1080-1084, 2017 | 66 | 2017 |
Marion Koopmanshttps://ncoh.nl在 erasmusmc.nl 的电子邮件经过验证
